ESPR - Esperion Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$3.19
DETAILS
HIGH:
$3.28
LOW:
$3.16
MEDIAN:
$3.16
CONSENSUS:
$3.19
UPSIDE:
1.92%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 67.9% |
| EBIT Margin | 15.0% |
| EBITDA Margin | 15.0% |
| Operating Margin | 15.0% |
| Pretax Margin | -5.2% |
| Cont. Ops Margin | -5.6% |
| Net Margin | -5.6% |
| Bottom Line Margin | -5.6% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 0.56 |
| Quick Ratio | 0.21 |
| Solvency Ratio | -0.029 |
| Cash Ratio | 0.56 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings |
-33.91
Peers avg: 27.7
|
| PEG Ratio | 0.56 |
| Forward PEG | 0.56 |
| Price/Book | -2.55 |
| Price/Sales | 1.91 |
| Price/FCF | -58.74 |
| Price/Op Cash Flow | -58.74 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 1.1763 |
| Debt/Equity | -1.8148 |
| Debt/Capital | 2.2273 |
| Long-Term Debt/Capital | 2.9396 |
| Financial Leverage | -1.54 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | -19.57 |
| Operating Cash Flow Ratio | -0.044 |
| Operating Cash Flow/Sales | -3.2% |
| Free Cash Flow/Operating Cash Flow | 100.0% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | 0.34 |
| Interest Coverage | 0.7124 |
| Short-Term Operating Cash Flow Coverage | -0.15 |
| Operating Cash Flow Coverage | -0.02 |
| Capital Expenditure Coverage | 0.00 |
| Dividend + Capital Expenditure Coverage | 0.00 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 1.94 |
| EPS | -0.109 |
| Debt/Share | 3.0433 |
| Cash/Share | 0.81 |
| Book Value/Share | -1.45 |
| Tangible BV/Share | -1.45 |
| Equity/Share | -1.45 |
| Operating Cash Flow/Share | -0.063 |
| Capital Expenditure/Share | 0.000 |
| FCF/Share | -0.063 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 1.088 |
| Earnings Before Tax/EBIT | -0.346 |
| Price/Fair Value | -2.55 |
| Debt/Market Cap | 0.7117 |
| Effective Tax Rate | -8.8% |
| Enterprise Value Multiple | 19.07 |